6533b7d2fe1ef96bd125dfdd

RESEARCH PRODUCT

Implementation of a gene panel for genetic diagnosis of primary ciliary dyskinesia

Alba Torrent-vernettaInés De Mir MessaSilvia Castillo-corullónSandra Rovira-amigoAmparo EscribanoMarta Garrido-pontnouEsther Amengual PierasÓScar Asensio De La CruzIgnacio Iglesias-serranoNoelia Baz-redónMónica Fernández-cancioEduardo F. TizzanoAna ReulaRosanel Amaro-rodríguezCarlos Martín De VicenteSilvia GartnerGerardo Vizmanos-lamotteFrancisco DasíEva PolverinoNúria Camats-tarruellaMaría Del Mar Martínez-collsElena García-arumíIda ParamonovAntonio Moreno-galdóMiguel Armengot-carcellerMiguel Armengot-carcellerMiguel Armengot-carcellerM. Araceli Caballero-rabascoMaría AntolínMaria Cols-roig

subject

business.industryGeneral Medicinemedicine.diseaseCompound heterozygosityBioinformatics03 medical and health sciences0302 clinical medicine030228 respiratory systemGene panelCohortotorhinolaryngologic diseasesMedicineGenetic diagnosisbusinessGenePrimary ciliary dyskinesia

description

Abstract Introduction Primary ciliary dyskinesia (PCD) is characterized by an alteration in the ciliary structure causing difficulty in the clearance of respiratory secretions. Diagnosis is complex and based on a combination of techniques. The objective of this study was to design a gene panel including all known causative genes, and to corroborate their diagnostic utility in a cohort of Spanish patients. Methods This was a multicenter cross-sectional study of patients with a high suspicion of PCD according to European Respiratory Society criteria. We designed a gene panel for massive sequencing using SeqCap EZ capture technology that included 44 genes associated with PCD. Results We included 79 patients, 53 of whom had a diagnosis of confirmed or highly probable PCD. The sensitivity of the gene panel was 81.1%, with a specificity of 100%. Candidate variants were found in some of the genes of the panel in 43 patients with PCD, 51.2% (22/43) of whom were homozygotes and 48.8% (21/43) compound heterozygotes. The most common causative genes were DNAH5 and CCDC39. We found 52 different variants, 36 of which were not previously described in the literature. Conclusions The design and implementation of a tailored gene panel produces a high yield in the genetic diagnosis of PCD. This panel provides a better understanding of the causative factors involved in these patients and lays down the groundwork for future therapeutic approaches.

https://doi.org/10.1016/j.arbr.2021.01.003